{"id":"https://openalex.org/W2560801337","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.10071","title":"Advanced well-differentiated/dedifferentiated liposarcomas: Role of chemotherapy and survival.","display_name":"Advanced well-differentiated/dedifferentiated liposarcomas: Role of chemotherapy and survival.","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W2560801337","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.10071","mag":"2560801337"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.10071","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.10071","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.10071","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084836759","display_name":"Maud Toulmonde","orcid":"https://orcid.org/0000-0003-3896-9274","observed_orcids":["https://orcid.org/0000-0003-3896-9274"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Toulmonde","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060949051","display_name":"Anto\u00eene Italiano","orcid":"https://orcid.org/0000-0002-8540-5351","observed_orcids":["https://orcid.org/0000-0002-8540-5351"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Italiano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052242950","display_name":"Nicolas Penel","orcid":"https://orcid.org/0000-0001-5243-1548","observed_orcids":["https://orcid.org/0000-0001-5243-1548"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Penel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012782858","display_name":"Angela Cioffi","orcid":"https://orcid.org/0000-0001-8290-6815","observed_orcids":["https://orcid.org/0000-0001-8290-6815"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Cioffi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090103193","display_name":"Axel Le Cesne","orcid":"https://orcid.org/0000-0002-8006-8659","observed_orcids":["https://orcid.org/0000-0002-8006-8659"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Le Cesne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082347575","display_name":"Nicol\u00e1s Isambert","orcid":"https://orcid.org/0000-0003-3596-2114","observed_orcids":["https://orcid.org/0000-0003-3596-2114"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Isambert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080620486","display_name":"Emmanuelle Bompas","orcid":"https://orcid.org/0000-0003-4414-7760","observed_orcids":["https://orcid.org/0000-0003-4414-7760"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Bompas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065856111","display_name":"Florence Duffaud","orcid":"https://orcid.org/0000-0002-2057-3557","observed_orcids":["https://orcid.org/0000-0002-2057-3557"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Duffaud","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074461929","display_name":"Anna Patrikidou","orcid":"https://orcid.org/0000-0001-5066-601X","observed_orcids":["https://orcid.org/0000-0001-5066-601X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Patrikidou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068677359","display_name":"Robert G. Maki","orcid":"https://orcid.org/0000-0002-9853-2528","observed_orcids":["https://orcid.org/0000-0002-9853-2528"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. G. Maki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113533108","display_name":"J.M. Coindre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Coindre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042202815","display_name":"Jean\u2010Yves Blay","orcid":"https://orcid.org/0000-0001-7190-120X","observed_orcids":["https://orcid.org/0000-0001-7190-120X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Blay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5073741289","display_name":"Binh Bui Nguyen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Bui Nguyen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"10071","last_page":"10071"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11638","display_name":"Cardiac tumors and thrombi","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/well-differentiated-liposarcoma","display_name":"well-differentiated liposarcoma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/dedifferentiated-liposarcoma","display_name":"dedifferentiated liposarcoma","score":1.0},{"id":"https://openalex.org/keywords/advanced-soft-tissue-sarcoma","display_name":"advanced soft tissue sarcoma","score":0.8489999771118164},{"id":"https://openalex.org/keywords/metastatic-disease","display_name":"metastatic disease","score":0.6200000047683716},{"id":"https://openalex.org/keywords/anthracycline-based-chemotherapy","display_name":"anthracycline chemotherapy","score":0.8289999961853027},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.8309999704360962},{"id":"https://openalex.org/keywords/dacarbazine","display_name":"dacarbazine","score":0.7900000214576721},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6880000233650208},{"id":"https://openalex.org/keywords/performance-status","display_name":"performance status","score":0.921999990940094},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7760000228881836},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.40700000524520874},{"id":"https://openalex.org/keywords/peritoneal-sarcomatosis","display_name":"peritoneal sarcomatosis","score":0.7570000290870667},{"id":"https://openalex.org/keywords/retroperitoneal-sarcoma","display_name":"retroperitoneal sarcoma","score":0.6980000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9290682077407837},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.67794269323349},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.5897848606109619},{"id":"https://openalex.org/C2776387010","wikidata":"https://www.wikidata.org/wiki/Q408717","display_name":"Eribulin","level":5,"score":0.583089292049408},{"id":"https://openalex.org/C2780752271","wikidata":"https://www.wikidata.org/wiki/Q2637746","display_name":"Trabectedin","level":4,"score":0.5599368214607239},{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.5461013913154602},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.52692711353302},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5154153108596802},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5079925656318665},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4766560196876526},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.450738787651062},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.4497895836830139},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4382507801055908},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4296576976776123},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.41852980852127075},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4153614938259125},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4132276177406311},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40497297048568726},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.35868820548057556},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.3323063850402832},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3064698874950409},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.27869755029678345},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.18923339247703552},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.16207388043403625},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.10071","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.10071","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.10071","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4280568057","https://openalex.org/W4392649987","https://openalex.org/W4408686233","https://openalex.org/W2965171334","https://openalex.org/W2755349712","https://openalex.org/W7127957421","https://openalex.org/W4297174462","https://openalex.org/W4402566076","https://openalex.org/W1997594001","https://openalex.org/W3088305550"],"abstract_inverted_index":{"10071":[0],"Background:":[1],"Data":[2],"regarding":[3],"the":[4,37,201,262],"role":[5],"of":[6,30,36,223,278,306],"systemic":[7,224],"therapy":[8],"in":[9,152,164,281,322,331],"patients":[10],"(pts)":[11],"with":[12,26,158,206,267,274,283,308,333],"advanced":[13,284,309],"well-differentiated/dedifferentiated":[14],"liposarcomas":[15],"(WLPS/DDLPS)":[16],"are":[17],"limited.":[18],"Methods:":[19],"From":[20],"2000":[21],"to":[22,34,297],"2010,":[23],"166":[24],"pts":[25,55,60,77,93,100,108,117,154,165,174,218,282,307,332],"a":[27,120,275],"confirmed":[28],"diagnosis":[29],"WDLPS/DDLPS":[31,310],"were":[32,261],"referred":[33],"one":[35],"8":[38],"participating":[39],"institutions,":[40],"and":[41,58,91,250],"their":[42],"medical":[43],"records":[44],"reviewed.":[45],"Results:":[46],"Median":[47,182,230],"age":[48],"was":[49,150,162,186,200,234],"63":[50],"years":[51],"(range":[52],"34-84).":[53],"Thirty":[54],"had":[56,61,79,95,102,176],"WDLPS":[57],"136":[59],"DDLPS.":[62],"Primary":[63],"tumor":[64],"sites":[65],"were:":[66,137],"retroperitoneum":[67],"n=120":[68],"(73%),":[69],"limb":[70],"n=19":[71],"(11%),":[72,155],"other":[73,323],"n=27":[74],"(16%).":[75],"111":[76],"(67%)":[78],"metastatic":[80,105,316],"disease":[81,178,317],"(peritoneal":[82],"sarcomatosis":[83],"n=75;":[84],"lung":[85],"n=30,":[86],"liver":[87],"n=19,":[88],"bone":[89],"n=5)":[90],"55":[92],"(33%)":[94],"locoregional":[96],"unresectable":[97],"disease.":[98],"27":[99],"(16%)":[101],"\u2265":[103,198],"2":[104,199],"sites.":[106],"103":[107],"(62%)":[109],"received":[110,119,220],"1st":[111,121],"line":[112,122],"single":[113,293],"agent":[114,294],"chemotherapy.":[115],"131":[116],"(79%)":[118],"anthracycline-containing":[123],"regimen":[124],"(doxorubicin":[125],"n=64,":[126],"doxorubicin":[127],"+":[128],"ifosfamide":[129],"and/or":[130],"dacarbazine:":[131],"n=45,":[132],"other:":[133],"n=22).":[134],"Non-anthracycline":[135],"regimens":[136],"metronomic":[138],"cyclophosphamide":[139],"or":[140,303],"etoposide:":[141],"n=17;":[142],"trabectedin:":[143],"n=4,":[144],"others:":[145],"n=14.":[146],"RECIST":[147],"objective":[148],"response":[149,290],"observed":[151],"18":[153],"all":[156],"treated":[157],"anthracyclines.":[159],"Response":[160],"rate":[161,277,291],"higher":[163,289],"receiving":[166],"combination":[167],"chemotherapy:":[168],"17%":[169],"vs":[170],"7%,":[171],"p=0.03.":[172],"62":[173],"(37%)":[175],"stable":[177],">":[179],"6":[180],"months.":[181],"progression-free":[183],"survival":[184,232],"(PFS)":[185],"5.2":[187],"months":[188,236],"(95%":[189,237],"CI:":[190,238],"3.4-7.0).":[191],"On":[192,240],"multivariate":[193,241],"analysis,":[194,242],"performance":[195],"status":[196],"(PS)":[197],"sole":[202,263],"factor":[203],"significantly":[204,265],"associated":[205,266,273],"poor":[207,268,334],"PFS":[208,302],"(Hazard":[209],"ratio":[210],"[HR]=":[211],"2.2;":[212,254],"95%":[213,246,255],"CI":[214,247,256],"1.4\u20133.5;":[215],"p<0.0001).":[216],"77":[217],"(46%)":[219],"further":[221],"lines":[222],"treatments":[225],"(median:":[226],"1,":[227],"range":[228],"1-5).":[229],"overall":[231],"(OS)":[233],"15.4":[235],"10.7-20.1).":[239],"PS":[243],"\u22652":[244],"(HR=2.1;":[245],"1.1\u20133.9;":[248],"p=0.026)":[249],"lymphopenia":[251],"<1000/mm3":[252],"(HR=":[253],"1.2\u20133.9;":[257],"p":[258],"=":[259],"0.01)":[260],"factors":[264],"OS.":[269,304],"Conclusions:":[270],"Chemotherapy":[271],"is":[272,311,318],"non-progression":[276],"about":[279],"50%":[280],"WDLPS/DDLPS.":[285],"Combination":[286],"chemotherapy":[287],"gives":[288],"than":[292,321],"but":[295],"appears":[296],"have":[298],"no":[299],"impact":[300],"on":[301],"OS":[305],"poor,":[312],"even":[313],"if":[314],"visceral":[315],"less":[319],"frequent":[320],"sarcomas.":[324],"Best":[325],"supportive":[326],"care":[327],"should":[328],"be":[329],"considered":[330],"PS.":[335]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-07T09:51:55.459714","created_date":"2016-12-16T00:00:00"}